Encompass Health Corporation revised earnings guidance for the year 2022. For the year, the company expects net operating revenue of $4,320 million to $4,350 million compared to pervious guidance of $4,250 million to $4,300 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
82.73 USD | -0.08% | +5.23% | +24.00% |
Apr. 25 | Encompass Health Corporation Provides Earnings Guidance for 2024 | CI |
Apr. 25 | Transcript : Encompass Health Corporation, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.00% | 8.28B | |
-22.63% | 15.76B | |
+3.60% | 12.34B | |
+3.65% | 11.52B | |
+9.80% | 11.02B | |
-2.19% | 7.8B | |
+20.75% | 7.2B | |
+4.53% | 6.67B | |
+49.97% | 4.64B | |
-5.01% | 4.25B |
- Stock Market
- Equities
- EHC Stock
- News Encompass Health Corporation
- Encompass Health Corporation Revises Earnings Guidance for the Year 2022